Accepted (ET)
4:17 PM
Sep 17, 2026
Filed
Sep 17, 2026
Documents
1
Size
5.0 KB
Summary
Medtronic (MDT) EVP Harry Skip Kiil Sells 1,483 Shares
What Happened Harry Skip Kiil, EVP & President, Cardiovascular at Medtronic plc (MDT), reported a sale of 1,483 shares on 2026-09-16. The shares were disposed at $93.65 each, for a gross transaction value of approximately $138,883. This was a sale (transaction code S); sales are common insider activity and do not by themselves indicate a change in company prospects.
Key Details
- Transaction date and price: 2026-09-16 at $93.65 per share.
- Shares sold: 1,483; gross proceeds ≈ $138,883.
- Transaction type: Reported as an open-market or private sale (Form 4 lists "open market or private sale").
- Shares owned after transaction: Not provided in the data supplied.
- Filing: Form 4 filed 2026-09-17 (appears timely; no late‑filing flag noted).
- No footnotes, 10b5-1 plan, option exercise, gift, or tax‑withholding details were included in the provided information.
Context
- This transaction was a straightforward sale (S). Unlike purchases, insider sales are often routine (e.g., portfolio rebalancing or liquidity needs) and should not be interpreted alone as a signal about company fundamentals.
- Retail investors should consider this alongside other insider filers, company disclosures, and broader market/company fundamentals before drawing conclusions.